AIFarm, Ltd.
AIFM · OTC
12/31/2019 | 9/30/2019 | 6/30/2019 | 3/31/2019 | |
|---|---|---|---|---|
| Market Cap | $678 | $843 | $1,286 | $1,845 |
| - Cash | $88 | $169 | $94 | $146 |
| + Debt | $55 | $0 | $0 | $0 |
| Enterprise Value | $644 | $674 | $1,192 | $1,699 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$60 | -$219 | -$76 | -$135 |
| % Margin | – | – | – | – |
| Net Income | -$116 | -$219 | -$76 | -$135 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.19 | -0.39 | -0.14 | -0.26 |
| % Growth | 51.3% | -178.6% | 46.2% | – |
| Operating Cash Flow | -$171 | -$157 | -$130 | -$133 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$171 | -$157 | -$130 | -$133 |